vs

Side-by-side financial comparison of ALUMIS INC. (ALMS) and Palladyne AI Corp. (PDYN). Click either name above to swap in a different company.

ALUMIS INC. is the larger business by last-quarter revenue ($2.7M vs $1.7M, roughly 1.6× Palladyne AI Corp.). ALUMIS INC. runs the higher net margin — 2225.1% vs -89.9%, a 2315.0% gap on every dollar of revenue. Palladyne AI Corp. produced more free cash flow last quarter ($-8.7M vs $-107.0M).

ALUMIS INC. is a clinical-stage biopharmaceutical company focused on developing innovative targeted therapies for patients suffering from autoimmune and inflammatory disorders. It advances multiple product candidates through clinical trials, aiming to address unmet medical needs for patient populations across global markets.

Palladyne AI Corp. is an American company known for most of its existence primarily as a developer of robots. Palladyne was founded in 1983 as Sarcos Research Corporation. In 2023, Sarcos shifted its business focus to the development of artificial intelligence (AI) software for robotic applications, discontinuing its hardware operations. In March 2024, the company changed its name to Palladyne AI.

ALMS vs PDYN — Head-to-Head

Bigger by revenue
ALMS
ALMS
1.6× larger
ALMS
$2.7M
$1.7M
PDYN
Higher net margin
ALMS
ALMS
2315.0% more per $
ALMS
2225.1%
-89.9%
PDYN
More free cash flow
PDYN
PDYN
$98.2M more FCF
PDYN
$-8.7M
$-107.0M
ALMS

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
ALMS
ALMS
PDYN
PDYN
Revenue
$2.7M
$1.7M
Net Profit
$59.3M
$-1.5M
Gross Margin
15.6%
Operating Margin
-5271.5%
-560.7%
Net Margin
2225.1%
-89.9%
Revenue YoY
118.3%
Net Profit YoY
205.0%
97.2%
EPS (diluted)
$0.77
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALMS
ALMS
PDYN
PDYN
Q4 25
$1.7M
Q3 25
$860.0K
Q2 25
$2.7M
$1.0M
Q1 25
$17.4M
$1.7M
Q4 24
$761.0K
Q3 24
$871.0K
Q2 24
$2.7M
Q1 24
$3.4M
Net Profit
ALMS
ALMS
PDYN
PDYN
Q4 25
$-1.5M
Q3 25
$-3.7M
Q2 25
$59.3M
$-7.5M
Q1 25
$-99.0M
$22.8M
Q4 24
Q3 24
$-7.1M
Q2 24
$-5.3M
Q1 24
$-7.2M
Gross Margin
ALMS
ALMS
PDYN
PDYN
Q4 25
15.6%
Q3 25
46.4%
Q2 25
53.3%
Q1 25
79.4%
Q4 24
27.2%
Q3 24
45.0%
Q2 24
79.0%
Q1 24
45.2%
Operating Margin
ALMS
ALMS
PDYN
PDYN
Q4 25
-560.7%
Q3 25
-937.8%
Q2 25
-5271.5%
-797.4%
Q1 25
-583.9%
-405.3%
Q4 24
Q3 24
-838.0%
Q2 24
-213.3%
Q1 24
-213.7%
Net Margin
ALMS
ALMS
PDYN
PDYN
Q4 25
-89.9%
Q3 25
-434.9%
Q2 25
2225.1%
-737.6%
Q1 25
-569.1%
1330.9%
Q4 24
Q3 24
-814.7%
Q2 24
-196.2%
Q1 24
-210.1%
EPS (diluted)
ALMS
ALMS
PDYN
PDYN
Q4 25
$-0.02
Q3 25
$-0.09
Q2 25
$0.77
$-0.20
Q1 25
$-1.82
$0.55
Q4 24
Q3 24
$-0.27
Q2 24
$-0.20
Q1 24
$-0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALMS
ALMS
PDYN
PDYN
Cash + ST InvestmentsLiquidity on hand
$486.3M
$47.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$485.3M
$74.7M
Total Assets
$610.9M
$95.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALMS
ALMS
PDYN
PDYN
Q4 25
$47.1M
Q3 25
$57.1M
Q2 25
$486.3M
$62.7M
Q1 25
$208.7M
$46.6M
Q4 24
$40.1M
Q3 24
$21.3M
Q2 24
$25.8M
Q1 24
$31.8M
Stockholders' Equity
ALMS
ALMS
PDYN
PDYN
Q4 25
$74.7M
Q3 25
$51.8M
Q2 25
$485.3M
$53.8M
Q1 25
$168.3M
$28.3M
Q4 24
$-9.5M
Q3 24
$23.4M
Q2 24
$29.8M
Q1 24
$34.2M
Total Assets
ALMS
ALMS
PDYN
PDYN
Q4 25
$95.7M
Q3 25
$72.9M
Q2 25
$610.9M
$78.3M
Q1 25
$261.3M
$63.3M
Q4 24
$56.3M
Q3 24
$38.7M
Q2 24
$45.1M
Q1 24
$50.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALMS
ALMS
PDYN
PDYN
Operating Cash FlowLast quarter
$-106.4M
$-8.5M
Free Cash FlowOCF − Capex
$-107.0M
$-8.7M
FCF MarginFCF / Revenue
-4012.3%
-526.2%
Capex IntensityCapex / Revenue
23.1%
14.2%
Cash ConversionOCF / Net Profit
-1.79×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALMS
ALMS
PDYN
PDYN
Q4 25
$-8.5M
Q3 25
$-6.3M
Q2 25
$-106.4M
$-5.3M
Q1 25
$-80.4M
$-7.5M
Q4 24
$-22.6M
Q3 24
$-4.5M
Q2 24
$-5.8M
Q1 24
$-7.2M
Free Cash Flow
ALMS
ALMS
PDYN
PDYN
Q4 25
$-8.7M
Q3 25
$-6.7M
Q2 25
$-107.0M
Q1 25
$-80.4M
$-7.6M
Q4 24
$-22.9M
Q3 24
$-4.5M
Q2 24
$-5.9M
Q1 24
$-7.3M
FCF Margin
ALMS
ALMS
PDYN
PDYN
Q4 25
-526.2%
Q3 25
-776.0%
Q2 25
-4012.3%
Q1 25
-462.3%
-445.0%
Q4 24
-3008.1%
Q3 24
-517.8%
Q2 24
-218.9%
Q1 24
-212.1%
Capex Intensity
ALMS
ALMS
PDYN
PDYN
Q4 25
14.2%
Q3 25
44.7%
Q2 25
23.1%
0.0%
Q1 25
0.2%
5.4%
Q4 24
34.8%
Q3 24
1.4%
Q2 24
5.3%
Q1 24
1.8%
Cash Conversion
ALMS
ALMS
PDYN
PDYN
Q4 25
Q3 25
Q2 25
-1.79×
Q1 25
-0.33×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons